These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29454646)

  • 1. Alteration of CCR6
    Sun H; Geng W; Cui H; Liang G; Fu Y; Zhang Z; Jiang Y; Ding H; Xu J; Shang H
    Cell Immunol; 2018 May; 327():47-53. PubMed ID: 29454646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.
    Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
    Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
    Khoury G; Anderson JL; Fromentin R; Hartogenesis W; Smith MZ; Bacchetti P; Hecht FM; Chomont N; Cameron PU; Deeks SG; Lewin SR
    AIDS; 2016 Jun; 30(10):1511-20. PubMed ID: 26807971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.
    Gosselin A; Wiche Salinas TR; Planas D; Wacleche VS; Zhang Y; Fromentin R; Chomont N; Cohen ÉA; Shacklett B; Mehraj V; Ghali MP; Routy JP; Ancuta P
    AIDS; 2017 Jan; 31(1):35-48. PubMed ID: 27835617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.
    Monteiro P; Gosselin A; Wacleche VS; El-Far M; Said EA; Kared H; Grandvaux N; Boulassel MR; Routy JP; Ancuta P
    J Immunol; 2011 Apr; 186(8):4618-30. PubMed ID: 21398606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.
    Silvestri G; Munoz-Calleja C; Bagnarelli P; Piedimonte G; Clementi M; Montroni M
    Clin Exp Immunol; 1998 Jan; 111(1):3-11. PubMed ID: 9472655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.
    Loiseau C; Requena M; Mavigner M; Cazabat M; Carrere N; Suc B; Barange K; Alric L; Marchou B; Massip P; Izopet J; Delobel P
    Mucosal Immunol; 2016 Sep; 9(5):1137-50. PubMed ID: 26883727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CXCR3 and CCR6 on CD4
    Silveira-Mattos PS; Narendran G; Akrami K; Fukutani KF; Anbalagan S; Nayak K; Subramanyam S; Subramani R; Vinhaes CL; Souza DO; Antonelli LR; Satagopan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
    Sci Rep; 2019 Feb; 9(1):1502. PubMed ID: 30728405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART).
    Böhler T; Wintergerst U; Linde R; Belohradsky BH; Debatin KM
    Pediatr Res; 2001 Jan; 49(1):101-10. PubMed ID: 11134499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia.
    Lyu M; Li Y; Hao Y; Lyu C; Huang Y; Sun B; Li H; Xue F; Liu X; Yang R
    Clin Exp Immunol; 2019 Mar; 195(3):345-357. PubMed ID: 30403287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
    Hua W; Jiao Y; Zhang H; Zhang T; Chen D; Zhang Y; Chen X; Wu H
    Immunol Invest; 2012; 41(1):1-14. PubMed ID: 21563924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.
    Alvarez Y; Tuen M; Shen G; Nawaz F; Arthos J; Wolff MJ; Poles MA; Hioe CE
    J Virol; 2013 Oct; 87(19):10843-54. PubMed ID: 23903844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.
    Cleret-Buhot A; Zhang Y; Planas D; Goulet JP; Monteiro P; Gosselin A; Wacleche VS; Tremblay CL; Jenabian MA; Routy JP; El-Far M; Chomont N; Haddad EK; Sekaly RP; Ancuta P
    Retrovirology; 2015 Dec; 12():102. PubMed ID: 26654242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.
    Wacleche VS; Goulet JP; Gosselin A; Monteiro P; Soudeyns H; Fromentin R; Jenabian MA; Vartanian S; Deeks SG; Chomont N; Routy JP; Ancuta P
    Retrovirology; 2016 Aug; 13(1):59. PubMed ID: 27553844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.